Related Experiment Video
Updated: Jun 11, 2025
09:20
An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
3.6K
MicroRNA dynamics in irisin-mediated signaling pathways within adipose tissue
Ming-Yun Ho1, Kai-Pin Chiu, Ming-Lung Tsai
1Division of Cardiology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan.
Journal of Biosciences
|October 8, 2024
Summary
Irisin regulates adipose tissue metabolism by influencing specific microRNAs (miRNAs) involved in energy balance and insulin sensitivity. This study identifies miRNA-758 and miRNA-668 as key regulators in irisin
Area of Science:
- Molecular Endocrinology
- Adipose Tissue Biology
- MicroRNA Therapeutics
Background:
- Irisin plays a crucial role in regulating adipose tissue metabolism, impacting energy homeostasis and insulin sensitivity.
- Understanding the molecular pathways, particularly microRNA (miRNA)-mediated signaling, is essential for developing strategies against obesity and metabolic disorders.
Purpose of the Study:
- To investigate the impact of irisin on gene expression in adipose tissue using a comprehensive miRNA transcriptomic approach.
- To identify specific miRNAs regulated by irisin and elucidate their roles in key signaling pathways.
Main Methods:
- Utilized miRNA transcriptomic analysis to identify differentially expressed miRNAs in adipocytes and murine white adipose tissue after irisin exposure.
- Performed signaling pathway and network analyses to determine the functional roles of identified miRNAs.
Main Results:
- Identified two key miRNAs, miRNA-758 and miRNA-668, significantly influenced by irisin.
- Demonstrated that both miRNA-758 and miRNA-668 act as crucial regulators in the leptin and CDK5 signaling pathways following irisin exposure.
Conclusions:
- Irisin modulates adipose tissue metabolism through miRNA-dependent regulation of leptin and CDK5 signaling pathways.
- The findings highlight specific miRNAs and genes involved in irisin's mechanism, offering potential targets for novel therapeutic strategies for metabolic diseases.
More Related Videos
09:41Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
2.7K
06:08Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
2.0K
Related Concept Videos
01:31Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
01:22MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
01:28Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
01:23RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K